215 related articles for article (PubMed ID: 15589325)
1. Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy.
de Haan EC; Moret EE; Wagenaar-Hilbers JP; Liskamp RM; Wauben MH
Mol Immunol; 2005 Feb; 42(3):365-73. PubMed ID: 15589325
[TBL] [Abstract][Full Text] [Related]
2. Limited plasticity in T cell recognition of modified T cell receptor contact residues in MHC class II bound peptides.
de Haan EC; Wagenaar-Hilbers JP; Liskamp RM; Moret EE; Wauben MH
Mol Immunol; 2005 Feb; 42(3):355-64. PubMed ID: 15589324
[TBL] [Abstract][Full Text] [Related]
3. Fine specificity of the myelin-reactive T cell repertoire: implications for TCR antagonism in autoimmunity.
Anderton SM; Manickasingham SP; Burkhart C; Luckcuck TA; Holland SJ; Lamont AG; Wraith DC
J Immunol; 1998 Oct; 161(7):3357-64. PubMed ID: 9759852
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of experimental autoimmune encephalomyelitis by MHC class II binding competitor peptides depends on the relative MHC binding affinity of the disease-inducing peptide.
Wauben MH; Joosten I; Schlief A; van der Zee R; Boog CJ; van Eden W
J Immunol; 1994 Apr; 152(8):4211-20. PubMed ID: 7511673
[TBL] [Abstract][Full Text] [Related]
5. Studies on T-cell receptors involved in experimental autoimmune encephalomyelitis using the complementary peptide recognition approach.
Xian CJ; Simmons RD; Willenborg DO; Vandenbark AA; Hashim GA; Carnegie PR
J Neurosci Res; 1995 Aug; 41(5):620-7. PubMed ID: 7563242
[TBL] [Abstract][Full Text] [Related]
6. Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis.
Burrows GG; Bebo BF; Adlard KL; Vandenbark AA; Offner H
J Immunol; 1998 Dec; 161(11):5987-96. PubMed ID: 9834080
[TBL] [Abstract][Full Text] [Related]
7. Cross-reactivity of myelin basic protein-specific T cells with multiple microbial peptides: experimental autoimmune encephalomyelitis induction in TCR transgenic mice.
Grogan JL; Kramer A; Nogai A; Dong L; Ohde M; Schneider-Mergener J; Kamradt T
J Immunol; 1999 Oct; 163(7):3764-70. PubMed ID: 10490973
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of molecular mimicry.
Wucherpfennig KW
J Autoimmun; 2001 May; 16(3):293-302. PubMed ID: 11334495
[TBL] [Abstract][Full Text] [Related]
9. Critical requirement for aspartic acid at position 82 of myelin basic protein 73-86 for recruitment of V beta 8.2+ T cells and encephalitogenicity in the Lewis rat.
Smeltz RB; Wauben MH; Wolf NA; Swanborg RH
J Immunol; 1999 Jan; 162(2):829-36. PubMed ID: 9916705
[TBL] [Abstract][Full Text] [Related]
10. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M).
Kaushansky N; Eisenstein M; Oved JH; Ben-Nun A
Int Immunol; 2008 Nov; 20(11):1439-49. PubMed ID: 18801757
[TBL] [Abstract][Full Text] [Related]
11. Rational optimization of tumor epitopes using in silico analysis-assisted substitution of TCR contact residues.
Shang X; Wang L; Niu W; Meng G; Fu X; Ni B; Lin Z; Yang Z; Chen X; Wu Y
Eur J Immunol; 2009 Aug; 39(8):2248-58. PubMed ID: 19593772
[TBL] [Abstract][Full Text] [Related]
12. T cell recognition of self and altered self antigens.
Nicholson LB; Kuchroo VK
Crit Rev Immunol; 1997; 17(5-6):449-62. PubMed ID: 9419432
[TBL] [Abstract][Full Text] [Related]
13. Soluble MHC II-peptide complexes induce antigen-specific apoptosis in T cells.
Nag B; Kendrick T; Arimilli S; Yu SC; Sriram S
Cell Immunol; 1996 May; 170(1):25-33. PubMed ID: 8660796
[TBL] [Abstract][Full Text] [Related]
14. Trimolecular interactions in experimental autoimmune demyelinating disease and prospects for immunotherapy.
Bell RB; Steinman L
Semin Immunol; 1991 Jul; 3(4):237-45. PubMed ID: 1718484
[TBL] [Abstract][Full Text] [Related]
15. Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes.
Bischof F; Wienhold W; Wirblich C; Malcherek G; Zevering O; Kruisbeek AM; Melms A
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12168-73. PubMed ID: 11593032
[TBL] [Abstract][Full Text] [Related]
16. Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99).
Vergelli M; Hemmer B; Utz U; Vogt A; Kalbus M; Tranquill L; Conlon P; Ling N; Steinman L; McFarland HF; Martin R
Eur J Immunol; 1996 Nov; 26(11):2624-34. PubMed ID: 8921948
[TBL] [Abstract][Full Text] [Related]
17. Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology.
Hemmer B; Vergelli M; Gran B; Ling N; Conlon P; Pinilla C; Houghten R; McFarland HF; Martin R
J Immunol; 1998 Apr; 160(8):3631-6. PubMed ID: 9558061
[TBL] [Abstract][Full Text] [Related]
18. Mapping immune responses to mRBP-3 1-16 peptide with altered peptide ligands.
Guyver CJ; Copland DA; Calder CJ; Sette A; Sidney J; Dick AD; Nicholson LB
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2027-35. PubMed ID: 16639012
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of a potent cyclic analogue of the myelin basic protein epitope MBP72-85: importance of the Ala81 carboxyl group and of a cyclic conformation for induction of experimental allergic encephalomyelitis.
Tselios T; Probert L; Daliani I; Matsoukas E; Troganis A; Gerothanassis IP; Mavromoustakos T; Moore GJ; Matsoukas JM
J Med Chem; 1999 Apr; 42(7):1170-7. PubMed ID: 10197961
[TBL] [Abstract][Full Text] [Related]
20. Activation thresholds determine susceptibility to peptide-induced tolerance in a heterogeneous myelin-reactive T cell repertoire.
McCue D; Ryan KR; Wraith DC; Anderton SM
J Neuroimmunol; 2004 Nov; 156(1-2):96-106. PubMed ID: 15465600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
